An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

New York Oncology Hematology, Albany

Duke University Medical Center, Durham

Cancer Centers of Florida, Orlando

Mary Crowley Medical Research Center, Dallas

Tyler Cancer Center, Tyler

University of Southern California School of Medicine, Los Angeles

University of Washington, Seattle

University of California, San Diego, San Diego

Cancer Care Northwest, Spokane